Acinetobacter species are bacteria causing healthcare-associated infections, such as pneumonia associated with the use of a ventilator, central line-associated bloodstream infections, and postoperative wound infections.
All EU Member States and two EEA countries (Island and Norway) reported data from invasive isolates, except for UK in 2020 and 2021. Roughly 76 percent of the participating countries had a high national representativeness, in terms of covered geographic areas, included acute care hospitals, and microorganisms causing infections.
*The aminoglycoside group includes only gentamicin and tobramycin from 2020 onwards.
Citation formats
Share of invasive resistant Acinetobacter in EU/EEA 2017-2021, by antimicrobial group
Acinetobacter species are bacteria causing mainly healthcare-associated infections. As of 2021, resistance to fluoroquinolone antibiotics was the most common form of Acinetobacter species antibiotic resistance in EU and EEA countries, with ** percent, followed by resistance to carbapenems and aminoglycosides. This statistic displays the percentage of invasive Acinetobacter species isolates resistant to antibiotics in EU/EEA countries between 2017 and 2021, by antimicrobial group.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
ECDC, & WHO. (April 14, 2023). Percentage of invasive Acinetobacter species isolates resistant to antibiotics in EU/EEA countries between 2017 and 2021, by antimicrobial group [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 27, 2026, from /statistics/1416993/share-of-invasive-resistant-acinetobacter-spp-in-eu-eea-by-antimicrobial-group/
ECDC, und WHO. "Percentage of invasive Acinetobacter species isolates resistant to antibiotics in EU/EEA countries between 2017 and 2021, by antimicrobial group." Chart. April 14, 2023. ÌÇÐÄÆƽâ°æ. Accessed July 27, 2026. /statistics/1416993/share-of-invasive-resistant-acinetobacter-spp-in-eu-eea-by-antimicrobial-group/
ECDC, WHO. (2023). Percentage of invasive Acinetobacter species isolates resistant to antibiotics in EU/EEA countries between 2017 and 2021, by antimicrobial group. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 27, 2026. /statistics/1416993/share-of-invasive-resistant-acinetobacter-spp-in-eu-eea-by-antimicrobial-group/
ECDC, and WHO. "Percentage of Invasive Acinetobacter Species Isolates Resistant to Antibiotics in Eu/Eea Countries between 2017 and 2021, by Antimicrobial Group." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 14 Apr 2023, /statistics/1416993/share-of-invasive-resistant-acinetobacter-spp-in-eu-eea-by-antimicrobial-group/
ECDC & WHO, Percentage of invasive Acinetobacter species isolates resistant to antibiotics in EU/EEA countries between 2017 and 2021, by antimicrobial group ÌÇÐÄÆƽâ°æ, /statistics/1416993/share-of-invasive-resistant-acinetobacter-spp-in-eu-eea-by-antimicrobial-group/ (last visited July 27, 2026)
Percentage of invasive Acinetobacter species isolates resistant to antibiotics in EU/EEA countries between 2017 and 2021, by antimicrobial group [Graph], ECDC, & WHO, April 14, 2023. [Online]. Available: /statistics/1416993/share-of-invasive-resistant-acinetobacter-spp-in-eu-eea-by-antimicrobial-group/
